Antimicrobial and anticancer activities of bisacodyl and it’s deacetylated metabolite DDPM

Proceedings of MOL2NET 2018, International Conference on Multidisciplinary Sciences, 4th edition Pub Date : 2019-01-11 DOI:10.3390/MOL2NET-04-06130

A. Fatma, Ricco Christophe, E. Mehdi, S. Maité, Ben Ali Mamdouh, F.G.D.A. Clotilde

{"title":"Antimicrobial and anticancer activities of bisacodyl and it’s deacetylated metabolite DDPM","authors":"A. Fatma, Ricco Christophe, E. Mehdi, S. Maité, Ben Ali Mamdouh, F.G.D.A. Clotilde","doi":"10.3390/MOL2NET-04-06130","DOIUrl":null,"url":null,"abstract":"The antibacterial activity of bisacodyl and its deacetylated metabolite, DDPM was investigated against Gram-positive pathogens including Staphylococcus aureus (ATCC 9144), Micrococcus luteus (LB14110), Salmonella enterica (NCTC 6017) with minimal inhibitory concentration (MIC) ranging from 12.5 to 25 μg/mL, 6.25 to 12.5 μg/mL and 25 to 50 μg/mL respectively. The results of antibacterial activity against Gram-negative foodborne Pseudomonas aeruginosa (ATCC 9027), Escherichia coli (ATCC 8739), show MIC values between 12.5-25 μg/mL and 25-50 μg/mL. The antifungal activity was also evaluated against the opportunistic pathogenic yeast Candida albicans (ATCC 2091) with MIC ranging from 12.5 to 25 μg/mL. Furthermore, the anticancer activity was evaluated against epithelial cervical cancer cell line (ATCC, Manassas,VA, USA). The results obtained indicated that bisacodyl and its deacetylated metabolite, DDPM have a cytotoxic activity at 63.69 μg/mL and 16.7 μg/mL respectively.","PeriodicalId":20475,"journal":{"name":"Proceedings of MOL2NET 2018, International Conference on Multidisciplinary Sciences, 4th edition","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of MOL2NET 2018, International Conference on Multidisciplinary Sciences, 4th edition","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/MOL2NET-04-06130","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

The antibacterial activity of bisacodyl and its deacetylated metabolite, DDPM was investigated against Gram-positive pathogens including Staphylococcus aureus (ATCC 9144), Micrococcus luteus (LB14110), Salmonella enterica (NCTC 6017) with minimal inhibitory concentration (MIC) ranging from 12.5 to 25 μg/mL, 6.25 to 12.5 μg/mL and 25 to 50 μg/mL respectively. The results of antibacterial activity against Gram-negative foodborne Pseudomonas aeruginosa (ATCC 9027), Escherichia coli (ATCC 8739), show MIC values between 12.5-25 μg/mL and 25-50 μg/mL. The antifungal activity was also evaluated against the opportunistic pathogenic yeast Candida albicans (ATCC 2091) with MIC ranging from 12.5 to 25 μg/mL. Furthermore, the anticancer activity was evaluated against epithelial cervical cancer cell line (ATCC, Manassas,VA, USA). The results obtained indicated that bisacodyl and its deacetylated metabolite, DDPM have a cytotoxic activity at 63.69 μg/mL and 16.7 μg/mL respectively.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

bisacodyl及其去乙酰化代谢物DDPM的抗菌和抗癌活性

研究了双草酰及其去乙酰化代谢物DDPM对革兰氏阳性病原菌金黄色葡萄球菌(ATCC 9144)、黄体微球菌(LB14110)、肠炎沙门氏菌(NCTC 6017)的抑菌活性，最小抑菌浓度(MIC)分别为12.5 ~ 25 μg/mL、6.25 ~ 12.5 μg/mL和25 ~ 50 μg/mL。对革兰氏阴性食源性铜绿假单胞菌(ATCC 9027)和大肠杆菌(ATCC 8739)的抑菌活性MIC值在12.5 ~ 25 μg/mL和25 ~ 50 μg/mL之间。对MIC为12.5 ~ 25 μg/mL的条件致病性白色念珠菌(ATCC 2091)进行了抑菌活性评价。此外，对上皮性宫颈癌细胞系(ATCC, Manassas,VA, USA)的抗癌活性进行了评估。结果表明，比沙草酰及其去乙酰化代谢物DDPM的细胞毒活性分别为63.69 μg/mL和16.7 μg/mL。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Proceedings of MOL2NET 2018, International Conference on Multidisciplinary Sciences, 4th edition

自引率

0.00%

发文量